Clinicians, discover the latest in research and clinical innovation from Johns Hopkins experts. Access educational videos, articles, CME courses and other resources from our world-renowned institution ...
Just over a year after its first phase 3 trial of its Engensis gene therapy for painful diabetic peripheral neuropathy (DPN ... At the moment treatment is limited to drugs like gabapentin and ...
Conclusion: Duloxetine has been approved for the treatment of MDD and pain associated with diabetic peripheral neuropathy in adults. This article reviews the pharmacology, pharmacokinetics ...
This growth is largely driven by the increasing prevalence of diabetic neuropathy, a common complication of diabetes that affects an ... propelled by the urgent need for effective treatments.” The ...